Evaluation of quality of generic brands of enrofloxacin available on the Ugandan market
View/ Open
Date
2020-11-11Author
Maseruka, Richard
Juba, Mark
Akello, lydia
Metadata
Show full item recordAbstract
ABSTRACT
This study intended to evaluate the quality of enrofloxacin brands available on the Ugandan
market for veterinary use. Enrofloxacin is a fluoroquinolone antibiotic with a broad-spectrum
activity commonly used for the treatment of various bacterial infections in animals and poultry.
Two batches of eight different brands of generic enrofloxacin were purchased from Veterinary
pharmacies in Kampala and Mbarara city. Standard physical and chemical tests for quality
surveillance were performed on the brands according to the methods outlined in the US
Pharmacopoeia 2013. High Performance Liquid Chromatography using a UV-VIS detector was
used for quantitative determination of enrofloxacin in the various brands. All brands assessed
were clear solutions showing a statistically significant difference between the obtained pH value
and the expected pH value of 7 as per USP specification at a P≤ 0.05. The product label on both
the primary and secondary pack of the brands had clearly stated the proprietary name, product
strength, manufacture and expiry dates, batch number, specific storage conditions, name of
manufacturer and country of origin of the drug. However, some key compendial information was
lacking on the label with only 37.5% (3/8) indicating the generic name, 87.5% (7/8) indicating
the route of administration while 25% (2/8) indicated the composition on the label. HPLC
analysis revealed that the mean drug concentration in all the brands were within compendial
specifications. The clarity of all the brands was also within compendial limits.